Characterization of seed nuclei in glucagon aggregation using light scattering methods and field-flow fractionation

Journal of Biological Engineering

Volumn 2, Issue , 2008, Pages

  Hoppe, Cindy C ^a   Nguyen, Lida T ^b   Kirsch, Lee E ^b   Wiencek, John M ^c  

^a IA United States   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c University of South Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; HYDROCHLORIC ACID; SODIUM HYDROXIDE;

ARTICLE; CONTROLLED STUDY; DRUG SOLUTION; FIELD FLOW FRACTIONATION; FILTRATION; GEL; LIGHT SCATTERING; MOLECULAR WEIGHT; POWDER; PRIORITY JOURNAL; PROTEIN AGGREGATION; SEPARATION TECHNIQUE;

EID: 48249110687     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1186/1754-1611-2-10     Document Type: Article

References (28)

1. Kim DY Shin NK Chang SG Shin HC Production of recombinant human glucagon in Escherichia coli by a novel fusion protein approach Biotechnology Techniques 1996, 10(9):669-672. 10.1007/BF00168477
2. Beaven GH Gratzer WB Davies HG Formation and structure of gels and fibrils from glucagon Eur J Biochem 1969, 11:37-42. 10.1111/ j.1432-1033.1969.tb00735.x 5353602
3. Costantino HR Langer R Klibanov AM Solid-phase aggregation of proteins under pharmaceutically relevant conditions J Pharm Sci 1994, 83(12):1662-1669. 10.1002/jps.2600831205 7891292
4. Stefani M Protein misfolding and aggregation: New examples in medicine and biology of the dark side of the protein world Biochim Biophys Acta 2004, 1739(1):5-25. 15607113
5. Bucciantini M Giannoni E Chiti F Baroni F Formigli L Zurdo JS Taddei N Ramponi G Dobson CM Stefani M Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 2002, 416(6880):507-511. 10.1038/416507a 11932737
6. Kirkitadze MD Bitan G Teplow DB Paradigm shifts in Alzheimer's disease and other neuro degenerative disorders: The emerging role of oligomeric assemblies J Neurosci Res 2002, 69(5):567-577. 10.1002/jnr.10328 12210822
7. Stefani M Dobson CM Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution J Mol Med 2003, 81(11):678-699. 10.1007/s00109-003-0464-5 12942175
8. Koo EH Lansbury PT Kelly JW Amyloid diseases: Abnormal protein aggregation in neurodegeneration Proc Natl Acad Sci USA 1999, 96(18):9989-9990. 33726 10468546 10.1073/pnas.96.18.9989
9. De Jong KL Incledon B Yip CM DeFelippis MR Amyloid fibrils of glucagon characterized by high-resolution atomic force microscopy Biophys J 2006, 91(5):1905-1914. 1544305 16766610 10.1529/biophysj.105.077438
10. Dong MD Hovgaard MB Xu SL Otzen DE Besenbacher F AFM study of glucagon fibrillation via oligomeric structures resulting in interwoven fibrils Nanotechnology 2006, 17(16):4003-4009. 10.1088/0957-4484/17/16/001
11. Pedersen JS Dikov D Flink JL Hjuler HA Christiansen G Otzen DE The changing face of glucagon fibrillation: Structural polymorphism and conformational imprinting J Mol Biol 2006, 355(3):501-523. 10.1016/ j.jmb.2005.09.100 16321400
12. Pedersen JS Flink JM Dikov D Otzen DE Sulfates dramatically stabilize a salt-dependent type of glucagon fibrils Biophys J 2006, 90(11):4181-4194. 1459509 16533857 10.1529/biophysj.105.070912
13. Onoue S Iwasa S Kojima T Katoh F Debari K Koh K Matsuda Y Yajima T Structural transition of glucagon in the concentrated solution observed by electrophoretic and spectroscopic techniques J Chromatogr A 2006, 1109(2):167-173. 10.1016/j.chroma.2005.11.130 16364337
14. Pallitto MM Murphy RM A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state Biophys J 2001, 81(3):1805-1822. 1301655 11509390
15. Lomakin A Teplow DB Kirschner DA Benedek GB Kinetic theory of fibrillogenesis of amyloid beta-protein Proc Natl Acad Sci USA 1997, 94(15):7942-7947. 21534 9223292 10.1073/pnas.94.15.7942
16. Li J Uversky VN Fink AL Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T Neurotoxicology 2002, 23(4-5):553-567. 10.1016/ S0161-813X(02)00066-9 12428728
17. Georgalis Y Starikov EB Hollenbach B Lurz R Scherzinger E Saenger W Lehrach H Wanker EE Huntingtin aggregation monitored by dynamic light scattering Proc Natl Acad Sci USA 1998, 95(11):6118-6121. 27595 9600927 10.1073/pnas.95.11.6118
18. Onoue S Ohshima K Debari K Koh K Shioda S Iwasa S Kashimoto K Yajima T Mishandling of the therapeutic peptide glucagon generates cytotoxic amyloidogenic fibrils Pharm Res 2004, 21(7):1274-1283. 10.1023/ B:PHAM.0000033016.36825.2c 15290870
19. Wittgren B Borgstrom J Piculell L Wahlund KG Conformational change and aggregation of kappa-carrageenan studied by flow field-flow fractionation and multiangle light scattering Biopolymers 1998, 45(1):85-96. 10.1002/ (SICI)1097-0282(199801)45:1<85::AID-BIP7>3.0.CO;2-V
20. Viebke C Williams PA The influence of temperature on the characterization of water-soluble polymers using asymmetric flow field-flow-fractionation coupled to multiangle laser light scattering Anal Chem 2000, 72(16):3896-3901. 10.1021/ac991205x 10959979
21. Fraunhofer W Winter G Coester C Asymmetrical flow field-flow fractionation and multiangle light scattering for analysis of gelatin nanoparticle drug carrier systems Anal Chem 2004, 76(7):1909-1920. 10.1021/ac0353031 15053651
22. Arifin DR Palmer AF Determination of size distribution and encapsulation efficiency of liposome-encapsulated hemoglobin blood substitutes using asymmetric flow field-flow fractionation coupled with multi-angle static light scattering Biotechnol Prog 2003, 19(6):1798-1811. 10.1021/ bp034120x 14656159
23. Provencher SW Inverse problems in polymer characterization - direct analysis of polydispersity with photon correlation spectroscopy Makromol Chem 1979, 180(1):201-209. 10.1002/macp.1979.021800119
24. Giddings JC Nonequilibrium theory of field-flow fractionation J Chem Phys 1968, 49(1):81-85. 10.1063/1.1669863
25. Wahlund KG Giddings JC Properties of an asymmetrical flow field-flow fractionation channel having one permeable wall Anal Chem 1987, 59(9):1332-1339. 10.1021/ac00136a016 3605623
26. Fraunhofer W Winter G The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics Eur J Pharm Biopharm 2004, 58(2):369-383. 10.1016/j.ejpb.2004.03.034 15296962
27. Wyatt PJ Light scattering and the absolute characterization of macromolecules Anal Chim Acta 1993, 272:1-40. 10.1016/ 0003-2670(93)80373-S
28. Creighton TE The general properties of protein structures Proteins: Structures and Molecular Properties New York, W. H. Freeman and Company 1993, 229.